A randomized phase 2 study of the thrombospondin-mimetic peptide ABT-510 in patients with previously untreated advanced renal cell carcinoma

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 4607-4607 ◽  
Author(s):  
S. W. Ebbinghaus ◽  
M. Hussain ◽  
N. M. Tannir ◽  
M. S. Gordon ◽  
A. A. Desai ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Phase 2 ◽  
Mimetic Peptide ◽  
Phase 2 Study ◽  
Randomized Phase 2

Clinical outcome after radical metastasectomy in renal cell carcinoma: Results from a randomized phase 2 study

2019 ◽  
Vol 18 (11) ◽  
pp. e3552
Author(s):  
G. Procopio ◽  
G. Apollonio ◽  
F. Cognetti ◽  
R. Miceli ◽  
M. Milella ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Clinical Outcome ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma

2017 ◽  
Vol 28 (4) ◽  
pp. 804-808 ◽  
Author(s):  
E. Jonasch ◽  
E. Hasanov ◽  
P.G. Corn ◽  
T. Moss ◽  
K.R. Shaw ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Randomized Phase 2

scholarly journals Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma

Cancer ◽  
2009 ◽  
pp. NA-NA ◽  
Author(s):  
Eric Jonasch ◽  
Paul Corn ◽  
Lance C. Pagliaro ◽  
Carla L. Warneke ◽  
Marcella M. Johnson ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Low Dose ◽  
Interferon Alfa ◽  
Advanced Renal Cell Carcinoma ◽  
Phase 2 ◽  
Phase 2 Trial ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document